Northwestern University received $7 million this year from the National Institute of General Medical Sciences to continue to push the boundaries of precision proteomics through new technologies and approaches to heart disease, cancer, neurological diseases and immuno-disorders, and to expand community engagement. The five-year grant builds upon the success of the National Resource for Translational and Developmental Proteomics (NRTDP), established in 2015 by Northwestern Proteomics, a center affiliated with Chemistry of Life Processes Institute.
“By providing far greater detail with next-generation technology, our national proteomics center is changing the fundamentals of how to read out proteins in basic and clinical research,” says Neil Kelleher, PhD, the Walter and Mary E. Glass Professor of Molecular Biosciences and Faculty Director, Northwestern Proteomics. “This is increasing the efficiency of detection and assignment of function to proteins and their myriad modifications.”
The grant will enable major upgrades in technology for cell-specific analysis of whole protein molecules — an approach known as top-down proteomics.
Original story by Lisa La Vallee published by Chemistry of Life Processes Institute on June 26, 2020.